Newco Voltarra Teams With Asia-Pacific Researchers On Zoledronic Acid For Osteoarthritis
This article was originally published in The Pink Sheet Daily
Executive Summary
Pennsylvania-based Voltarra has a combination product that includes a reformulated version of zoledronic acid ready to move into Phase III in osteoarthritis, but the program will move forward first in the Asia-Pacifc region, with U.S. and EU development intended down the road.